Samsung Biologics to open $2B drug manufacturing plant

Samsung Biologics to open $2B drug manufacturing plant

Source: 
Beckers Hospital Review
snippet: 

Samsung's drugmaker affiliate, called Samsung Biologics, is planning to build a $2 billion drug manufacturing plant to be completed in 2022, The Wall Street Journal reported.

The plant is set to be about 2,475,700 square feet, making it the largest in the world.